Your browser doesn't support javascript.
loading
T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related Donors.
Mariotti, Jacopo; Devillier, Raynier; Bramanti, Stefania; Sarina, Barbara; Furst, Sabine; Granata, Angela; Faucher, Catherine; Harbi, Samia; Morabito, Lucio; Chabannon, Christian; Carlo-Stella, Carmelo; Bouabdallah, Reda; Santoro, Armando; Blaise, Didier; Castagna, Luca.
Afiliación
  • Mariotti J; Bone Marrow Transplant Unit, Humanitas Clinical and Research Center, Rozzano, Italy. Electronic address: jacopo.mariotti@cancercenter.humanitas.it.
  • Devillier R; Department of Hematology, Transplantation Program, Institut Paoli-Calmettes, Marseille, France.
  • Bramanti S; Bone Marrow Transplant Unit, Humanitas Clinical and Research Center, Rozzano, Italy.
  • Sarina B; Bone Marrow Transplant Unit, Humanitas Clinical and Research Center, Rozzano, Italy.
  • Furst S; Department of Hematology, Transplantation Program, Institut Paoli-Calmettes, Marseille, France.
  • Granata A; Department of Hematology, Transplantation Program, Institut Paoli-Calmettes, Marseille, France.
  • Faucher C; Department of Hematology, Transplantation Program, Institut Paoli-Calmettes, Marseille, France.
  • Harbi S; Department of Hematology, Transplantation Program, Institut Paoli-Calmettes, Marseille, France.
  • Morabito L; Bone Marrow Transplant Unit, Humanitas Clinical and Research Center, Rozzano, Italy.
  • Chabannon C; Cell Therapy Unit, Institut Paoli Calmettes, Marseille, France; Medicine Faculty, Aix-Marseille Université, Marseille, France; Centre de Recherche en Cancérologie de Marseille, Marseille, France.
  • Carlo-Stella C; Bone Marrow Transplant Unit, Humanitas Clinical and Research Center, Rozzano, Italy; Department of Medical Biotechnology and Translational Medicine, University of Milano, Milano, Italy.
  • Bouabdallah R; Department of Hematology, Transplantation Program, Institut Paoli-Calmettes, Marseille, France.
  • Santoro A; Bone Marrow Transplant Unit, Humanitas Clinical and Research Center, Rozzano, Italy; Humanitas Clinical and Research Hospital, Humanitas University, Rozzano, Italy.
  • Blaise D; Department of Hematology, Transplantation Program, Institut Paoli-Calmettes, Marseille, France; Medicine Faculty, Aix-Marseille Université, Marseille, France; Centre de Recherche en Cancérologie de Marseille, Marseille, France.
  • Castagna L; Bone Marrow Transplant Unit, Humanitas Clinical and Research Center, Rozzano, Italy.
Biol Blood Marrow Transplant ; 24(3): 627-632, 2018 03.
Article en En | MEDLINE | ID: mdl-29197681

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Donantes de Tejidos / Enfermedad de Hodgkin / Linfocitos T / Transfusión de Linfocitos / Ciclofosfamida / Enfermedad Injerto contra Huésped / Antígenos HLA Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2018 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Donantes de Tejidos / Enfermedad de Hodgkin / Linfocitos T / Transfusión de Linfocitos / Ciclofosfamida / Enfermedad Injerto contra Huésped / Antígenos HLA Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2018 Tipo del documento: Article